When most people hear about E. coli, they think of food poisoning or stomach infections. However, emerging research is now uncovering a more complex picture — one involving certain strains of gut bacteria and their potential role in colorectal cancer development.
Studies suggest that specific strains of Escherichia coli (E. coli) may contribute to inflammation, DNA damage, and changes in the gut environment that could influence colorectal cancer risk and progression. (AACR Journals)
Not All E. Coli Are Harmful
E. coli naturally lives in the digestive tract, and many strains are completely harmless — some even support digestion and nutrient production.
However, researchers are particularly interested in a subtype known as colibactin-producing E. coli (often referred to as pks+ E. coli).
These strains produce a toxin called colibactin, which has been shown to damage DNA in colon cells.
Scientists have also identified a distinct “mutational signature” in some colorectal cancers that appears linked to exposure to this toxin, strengthening the association between these bacteria and cancer development.
How Gut Bacteria May Influence Cancer
The gut microbiome plays a key role in regulating:
- inflammation
- immune function
- metabolism
- and the integrity of the gut lining
When the microbiome becomes imbalanced (dysbiosis), it may contribute to:
- chronic inflammation
- increased intestinal permeability
- immune dysregulation
- oxidative stress
- altered cell signalling
Over time, these changes may create an internal environment that is less protective and more prone to disease development in susceptible individuals.
Certain strains of E. coli may also:
- attach to the intestinal lining
- produce DNA-damaging compounds
- stimulate inflammatory pathways
- influence tumour behaviour and progression
DNA Damage and Colibactin
One of the most significant discoveries in this area is the role of colibactin in DNA damage.
Research published in Cancer Discovery found that colibactin produces a unique mutation pattern seen in some colorectal cancers.
More recent studies suggest these bacterial toxins may act early in the disease process, potentially contributing to mutations years before cancer is diagnosed.
There is also growing interest in whether early-life exposure to these bacteria may be one factor contributing to rising colorectal cancer rates in younger adults. (Health)
The Microbiome and Treatment Outcomes
The role of the microbiome extends beyond cancer development.
Research shows gut bacteria influences:
- immune system activation
- inflammation levels
- chemotherapy tolerance
- immunotherapy response
- treatment side effects (PMC)
This is an evolving area of research, but it highlights how closely gut health and systemic health are connected.
Testing Your Microbiome
At-home stool tests are available that assess the microbiome in more detail than standard medical testing. These functional tests are often used by naturopaths and integrative healthcare practitioners to explore gut bacterial balance, diversity, and markers linked to inflammation and digestive function.
GP stool tests, on the other hand, are designed to detect specific pathogens such as bacteria, parasites, or viruses that may be causing an acute infection. They are very effective for investigating sudden or severe gastrointestinal illness.
However, they do not assess overall microbial balance or gut ecosystem function.
Microbiome testing provides a broader view, including:
- bacterial balance
- microbial diversity
- signs of dysbiosis
- inflammatory patterns within the gut
While these tests are not used to diagnose colorectal cancer, they provide useful insight into gut health patterns that are increasingly being studied in relation to inflammation and long-term disease risk.
How We Support Clients
While research in this area is still evolving, supporting a healthy microbiome is an important part of long-term digestive and immune health.
In clinical practice, support may include:
- improving dietary diversity and plant intake
- reducing ultra-processed foods
- supporting gut barrier integrity
- addressing chronic inflammation
- investigating persistent digestive symptoms early
- specific strains and probiotics to support your microbiome
- food as medicine – using specific foods to support the growth of beneficial bacterial
Our approach focuses on understanding the underlying drivers of symptoms and supporting the body through a personalised, integrative plan.
Final Thoughts
The relationship between the microbiome and colorectal cancer is one of the most rapidly developing areas in modern health research.
While it is unlikely that no single bacteria cause cancer on its own, certain microbial patterns may influence inflammation, DNA damage, and disease progression over time.
As research continues to evolve, gut health is increasingly being recognised as an important part of prevention, resilience, and overall wellbeing — particularly in complex chronic health conditions.
If you would like to know more about how microbiome testing can support your overall health and wellbeing book a consultation with one of our naturopaths.
Naturopath, Nutritionist and Buteyko Practitioner at Elemental Health, St. Ives - Sydney.